Compare
HCW Biologics Inc. vs Silo Pharma, Inc. vs Impact Biomedical Inc. vs BullFrog AI Holdings, Inc.
| Latest fiscal year | HCW Biologics Inc. HCWB | Silo Pharma, Inc. SILO | Impact Biomedical Inc. IBO | BullFrog AI Holdings, Inc. BFRG |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $54.2K | $72.1K | $32.0K | $116.7K |
| Revenue growth (YoY) | -97.9% | 0.0% | n/a | n/a |
| Gross margin | 20.0% | 38.6% | n/m (computed) | 18.8% |
| Operating margin | n/m | n/m | n/m | n/m |
| Net margin | n/m | n/m | n/m | n/m |
| Net income | -$7.96M | -$4.23M | -$11.84M | -$6.50M |
| EPS (Diluted) | -$10.63 | -$0.50 | -$0.38 | -$0.63 |
| Operating cash flow | -$13.39M | -$4.66M | -$1.89M | -$5.52M |
| Free cash flow | -$13.39M | n/a | n/a | n/a |
| Cash & equivalents | $1.95M | $4.75M | $3.0K | $2.18M |
| Total assets | $24.52M | $7.61M | $17.41M | $2.81M |
| Total liabilities | $21.76M | $1.30M | $1.85M | $672.0K |
| Shareholders' equity | $2.76M | $6.31M | $12.61M | $2.14M |
| Return on year-end equity | -287.9% | -67.0% | -93.9% | -304.2% |
| Shares outstanding | n/a | 13.32M | 104.62M | 11.42M |
Revenue, most recent five fiscal years
| Fiscal year | HCW Biologics Inc. | Silo Pharma, Inc. | Impact Biomedical Inc. | BullFrog AI Holdings, Inc. |
|---|---|---|---|---|
| Latest | $54.2K Ended 2025-12-31 | $72.1K Ended 2025-12-31 | $32.0K Ended 2025-12-31 | $116.7K Ended 2025-12-31 |
| 1 year earlier | $2.57M Ended 2024-12-31 | $72.1K Ended 2024-12-31 | n/a | n/a |
| 2 years earlier | $2.84M Ended 2023-12-31 | $72.1K Ended 2023-12-31 | n/a | $65.0K Ended 2023-12-31 |
| 3 years earlier | $6.72M Ended 2022-12-31 | $72.1K Ended 2022-12-31 | $50.0K Ended 2022-12-31 | $10.0K Ended 2022-12-31 |
| 4 years earlier | $0 Ended 2021-12-31 | n/a | n/a | n/a |